Healthcare -
Biotechnology - NASDAQ - US
$ 4.8325
124 %
$ 15 M
Market Cap
-0.15
P/E
BTAI - CAPITAL EXPENDITURES
Capital Expenditures BTAI - BioXcel Therapeutics, Inc.
-20 K
LAST VALUE
78.80%
2 YEAR CAGR
43.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR